hand in laptop pointing to email icon

Your dream job…could be 1 update away

Mylan High Paying Jobs, Compensation Information and Expert Network Connections

lightbulbWhat are the highest paying jobs at Mylan?

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

In 2007, the company acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, the company grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.

Mylan went public on the OTC market in February 1973. It was listed on the NASDAQ, and its shares were a component of the NASDAQ Biotechnology and the S&P 500 indices.

The company was founded in 1961 and developed and produced medicines for a wide range of medical disciplines, including oncology, anaphylaxis, antiretrovirals, cardiovascular, respiratory, dermatology, immunology, anesthesia and pain management, infectious disease, gastroenterology, diabetology/endocrinology, and women's healthcare.


Market Cap$8.5 billion
Revenue$11.5 billion
5 Year Trendarrow trend up+8.3%
Net Income$266.4 million
pie chartAnnual Report
stats icon
Total value of jobs:
stats icon
Average Pay:
stats icon
Total Experts:
stats icon
% Masters:

Top Experts at Mylan